Acute Upper Respiratory Tract Infection - When is Bacteria Involved?
1 other identifier
observational
48
1 country
1
Brief Summary
The purpose of this study is to find out if we can predict the progress of acute upper respiratory tract infection to acute bacterial rhinosinusitis in Finnish conscripts by symptoms, clinical, endoscopic or radiological findings, middle meatal swab samples or nitric oxide measurement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 17, 2012
CompletedFirst Posted
Study publicly available on registry
April 18, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedOctober 30, 2013
October 1, 2013
2 months
April 17, 2012
October 29, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bacterial maxillary sinusitis
Bacterial maxillary sinusitis defined as positive culture results from the maxillary puncture (either side)
2 months
Secondary Outcomes (1)
Bacterial sinusitis
2 months
Study Arms (2)
healthy conscripts
non allergic subjects who have not a history of recurrent rhinosinusitis
subjects with recurrent rhinosinusitis
subjects who have experienced recurrent rhinosinusitis episodes (3 during the previous 3 years)
Eligibility Criteria
Finnish conscripts from the prigade of Kainuu who suffer from acute common cold with nasal symptoms. Consecutive sample. Subjects with known allergies, nasal polyps and prior sinus surgery are excluded.
You may qualify if:
- Conscript with acute upper respiratory tract infection symptoms (nasal obstruction/decongestion, post nasal drip or nasal secretion) lasted for 2-4 days
You may not qualify if:
- Allergy, asthma, nasal polyposis, sinus surgery, autoimmune illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oulu University Hospitallead
- Finnish Defense Forcescollaborator
- The Central Hospital of Kajaanicollaborator
- Huslab, Clinical Microbiology, Virology and Immunologycollaborator
- University of Oulucollaborator
Study Sites (1)
Finnish Defence Force, Centre for Military Medicine
Kajaani, Kainuu, FI 87500, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Petri Koivunen, Dosent
Dept of Otolaryngology, University of Oulu, Finland
- PRINCIPAL INVESTIGATOR
Timo Koskenkorva, MD
Dept of Otolaryngology, University of Oulu, Finland
- PRINCIPAL INVESTIGATOR
Mervi Närkiö, MD
Finnish Defence Force
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2012
First Posted
April 18, 2012
Study Start
February 1, 2012
Primary Completion
April 1, 2012
Study Completion
April 1, 2014
Last Updated
October 30, 2013
Record last verified: 2013-10